Department of Pharmaceutical Analysis, Sri Venkateswara College of Pharmacy, RVS Nagar, Tirupati Rd, Chittoor, Andhra Pradesh 517127, India.
World Journal of Biology Pharmacy and Health Sciences, 2022, 12(01), 053–065.
Article DOI: 10.30574/wjbphs.2022.12.1.0145
DOI url: https://doi.org/10.30574/wjbphs.2022.12.1.0145
Received on 28 August 2022; revised on 06 October 2022; accepted on 09 October 2022
Imatinib, is an oral chemotherapy medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia and acute lymphocytic leukemia that are Philadelphia chromosome-positive, certain types of gastrointestinal stromal tumors, hypereosinophilic syndrome, chronic eosinophilic leukemia, systemic mastocytosis, and myelodysplastic syndrome. There are various analytical methods for estimation of the drug. This paper list outs the various analytical methods for the drug.
Imatinib; Anticancer; Analytical methods; Review.
Preview Article PDF
Thangabalan Boovizhikannan, Ramya Nethakara Mahesh, and Porkodi Sivakumar. Various analytical methods for estimation of Imatinib: A review. World Journal of Biology Pharmacy and Health Sciences, 2022, 12(01), 053–065.https://doi.org/10.30574/wjbphs.2022.12.1.0145